Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177788
Status:
COMPLETED
Last Update Posted:
2012-08-16
First Post:
2005-09-13
Brief Title:
Voriconazole as Prophylaxis for Liver Transplant Recipients
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Voriconazole as Prophylaxis for Liver Transplant Recipients
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients Endpoints would be occurrence of invasive fungal infection and fungal colonization Two groups will be compared patients who received voriconazole as prophylaxis and historical controls who did not receive this prophylaxis
Detailed Description:
The following variables will be followed time and location of positive cultures underlying diseases and severity of illness voriconazole usage prophylactically physical exam findings laboratory and radiographical data antimicrobial usage microbiological data and resistance patterns choice of antifungal drugs once organism identified suspected source of infection microbiological outcomes laboratory results demographic information medications clinical outcome gender weight ethnicity and past medical history
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None